Resources Contact Us Home
Binding peptides for carcinoembryonic antigen (CEA)

Image Number 5 for United States Patent #7438890.

The present invention provides binding moieties for CEA, which have a variety of uses wherever detecting, isolating or localizing CEA, and particularly CEA as opposed to cross-reactive antigens such as NCA, is advantageous. Particularly disclosed are synthetic, isolated polypeptides capable of binding CEA, which is overexpressed in adenocarcinomas of endodermally derived digestive system epithelia and fetal colon. Such polypeptides and disclosed derivatives are useful, e.g., as imaging agents for CEA-expressing tumors.

  Recently Added Patents
Vending machine
Traffic flow analysis mitigation using a cover signal
Device for installing conducting components in structures
Case for electronic device
System and method for leveraging independent innovation in entertainment content and graphics hardware
Antenna device
Electronic component
  Randomly Featured Patents
Finite amplitude distortion-based inhomogeneous pulse echo ultrasonic imaging
Compressible thermally-conductive interface
Polyester resin composition
Changeable articles of jewelry and method of using them
Cam-lock enhanced pressure switch contacts
Keyboard device with pointing device using strain gauges incorporated therein
Semiconductor memory device
Remote-controlled starter apparatus with starting detection capability
Low temperature reduction process for photomasks
Integrated circuit having an EEPROM, semiconductor wafer provided with such integrated circuits, and method of testing such a semiconductor wafer